DPT and Confab Complete $10 Million Capital Investment
PTSM: Pharmaceutical Technology Sourcing and Management
The investment includes facility upgrades and expansion of development capabilities.
DPT Laboratories, a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms, and Confab, a DPT company specializing in complex solids, semi-solids, and liquids, have completed a combined $10 million capital investment.
According to a press announcement from the company, DPT invested in a new compounding suite and upgrades to production filling lines. Additional upgrades include a remodeled front office area, enhanced security, and enhancement for further GMP compliance.
Confab, based in Montreal, made an investment to increase R&D capabilities with a new laboratory, new equipment, and expansion of its R&D team. According to a press announcement, Confab will now offer pharmaceutical development capabilities including formulation development, analytical method development, and technology transfers at commercial scale.
Source: DPT
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
